Beranda › Kanker (semua jenis) › California › Mountain View
Uji klinis Kanker (semua jenis) di Mountain View, CA
40 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Mountain View (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- Stanford University School of Medicine, Stanford · 5 mi jauhnya
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Menerima pesertaStudi observasional
- Stanford University, Palo Alto · 5 mi jauhnya
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Menerima pesertaFase 3
- Quetzal Site 5, Stanford · 5 mi jauhnya
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauhnya
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- Sutter Palo Alto Medical Foundation: Palo Alto, Palo Alto · 5 mi jauhnya
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- Stanford Cancer Center, Stanford · 5 mi jauhnya
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Menerima pesertaFase 2
- Stanford Cancer Institute, Stanford · 5 mi jauhnya
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Menerima pesertaFase 1
- Investigational Site Number: 403, Palo Alto · 5 mi jauhnya
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Menerima pesertaFase 3
- Research Site, Palo Alto · 5 mi jauhnya
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaStudi observasional
- Stanford, Palo Alto · 5 mi jauhnya
Prostate Active Surveillance Study
Menerima pesertaStudi observasional
- Stanford University, Stanford · 5 mi jauhnya
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Menerima pesertaFase 1
- Stanford University, Palo Alto · 5 mi jauhnya
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi jauhnya
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi jauhnya
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Menerima pesertaFase 1
- Stanford Cancer Center, Palo Alto · 5 mi jauhnya
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi jauhnya
- dan 1 lainnya
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Menerima pesertaFase 2
- 150, Palo Alto · 5 mi jauhnya
Evaluation of Grief Therapy Approaches for Bereaved Parents
Menerima peserta
- Stanford University (Data Collection Only), Stanford · 5 mi jauhnya
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Menerima pesertaFase 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi jauhnya
Childhood Cancer Survivor Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Stanford University School of Medicine, Stanford · 5 mi jauhnya
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Menerima peserta
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto · 5 mi jauhnya
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- Stanford University, Stanford · 5 mi jauhnya
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Menerima pesertaFase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi jauhnya
Galleri® in the Medicare Population.
Menerima pesertaSukarelawan sehat diterima
- Sutter Valley Hospitals PAMF Sutter, Palo Alto · 5 mi jauhnya
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Menerima pesertaFase 1
- GSK Investigational Site, Stanford · 5 mi jauhnya
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Menerima pesertaFase 1/2
- Lucille Packard Children's Hospital Stanford, Palo Alto · 5 mi jauhnya
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Menerima pesertaFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauhnya
Impact of the Coronavirus (COVID-19) on Patients With Cancer
Menerima pesertaStudi observasional
- Stanford University School of Medicine, Stanford · 5 mi jauhnya
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Menerima pesertaFase 2
- Byers Eye Institute at Stanford University, Palo Alto · 5 mi jauhnya
Engagement of Veterans With Lung Cancer
Menerima peserta
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi jauhnya
Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making
Menerima pesertaSukarelawan sehat diterima
- Stanford University, Palo Alto · 5 mi jauhnya
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Stanford University School of Medicine, Stanford · 5 mi jauhnya
Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
Menerima peserta
- Stanford University, Palo Alto · 5 mi jauhnya
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Menerima pesertaFase 1
- Stanford Cancer Institute, Palo Alto · 5 mi jauhnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Stanford · 5 mi jauhnya
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
Menerima pesertaStudi observasional
- Stanford Cancer Center, Palo Alto · 5 mi jauhnya
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Exai Bio Inc., Palo Alto · 5 mi jauhnya
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- Stanford Cancer Institute, Palo Alto · 5 mi jauhnya
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
Menerima pesertaFase 1/2
- Stanford University Cancer Institute, Stanford · 5 mi jauhnya
xPedite: A Study to Expedite DIPG and DMG Research
Menerima pesertaStudi observasional
- xCures, Inc., Los Altos · 2 mi jauhnya
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Studi lain di Mountain View
- Kanker Payudara25 studi
- Kanker Metastatik25 studi
- Kanker Paru Non-Sel Kecil21 studi
- Leukemia Mieloid Akut19 studi
- Kanker Ovarium19 studi
- Gangguan Spektrum Autisme17 studi
- Kanker Paru17 studi
- Gagal Jantung15 studi
- Kanker Prostat15 studi
- Autisme13 studi
- Leukemia Limfoblastik Akut13 studi
- Kanker Kolorektal13 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.